Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine

Blood

Volumn 87, Issue 4, 1996, Pages 1556-1560

  Wheaton, Susan ^b   Tallman, Martin S ^b   Hakimian, David ^b   Peterson, LoAnn ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CLADRIBINE; PENTOSTATIN;

ARTICLE; BONE MARROW BIOPSY; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HAIRY CELL LEUKEMIA; HUMAN; HUMAN TISSUE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030043304     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.4.1556.bloodjournal8741556     Document Type: Article

References (14)

1. Golomb HE, Catovsky D, Golde DW: Hairy cell leukemia. A clinical review based on 71 cases. Ann Intern Med 89:677, 1978
2. Piro L, Carrera C, Carson D, Beutler E: Lasting remissions in hairy cell leukemia by a single infusion of 2-chlorodeoxy-adenosine. N Engl J Med 322:1117, 1990
3. Estey E, Kurzrock R, Kantarjian H, O'Brien S, McCredie K, Beran M, Koller C, Keating M, Hirsch-Ginsberg C, Huh Y, Stass S, Freireich E: Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood 79:882, 1992
4. Tallman M, Hakimian D, Variakojis D, Koslow D, Sisney G, Rademaker A, Rose E, Kaul K: A single cycle of 2-chlorodeoxyadenosine results in complete remission in the majority of patients with hairy cell leukemia. Blood 80:2203, 1992
5. Hakimian D, Tallman MS, Kiley C, Peterson L: Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia. Blood 82:1798, 1993
6. Ellison D, Sharpe R, Robbins B, Spinosa J, Leopard J, Saven A, Piro L: Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia. Blood 84:4310, 1994
7. Hounieu H, Chittal S, Saati T, De Mascarel A, Sabittini E, Pileri S, Falini B, Ralfkiaer E, Le Tourneau A, Selves J, Voigt J, Laurent G, Diebold J, Delsol G: Hairy cell leukemia: Diagnosis of bone marrow involvement in paraffin-embedded sections with monoclonal antibody DBA.44. Am J Clin Pathol 98:26, 1992
8. + lymphocyte counts in patients with hairy cell leukemia. Blood 83:2906, 1994
9. Horny HP, Wehrmann M, Griesser H, Tiemann M, Bultmann B, Kaserling E: Investigation of bone marrow lymphocyte subsets in normal, reactive, and neoplastic states using paraffin-embedded biopsy specimens. Hematopathology 99:142, 1993
10. Bastie JN, d'Agay MF, Flandrin G, Daniel MT, Dabout D, Glaisner S, Degos L, Castaigne S: Hairy cell leukemia (HCL): A phase II prospective study about 28 patients treated with 2-chlorodeoxyadenosine (2CdA). Br J Haematol 87:209, 1994 (suppl 1, abstr)
11. Pileri S, Sabattini E, Poggi S, Merla E, Raspadore D, Benfenati D, Rondelli D, Benni M, Ventura MA, Falini B, Delsol G, Lauria F: Bone-marrow biopsy in hairy cell leukemia (HCL) patients. Histological and immunohistological analysis of 46 cases treated with different therapies. Leuk Lymph 14:67, 1994 (suppl 1)
12. Di Celle PF, Reato G, Raspadori D, Carbone A, Rondelli D, Lauria F, Foa R: Molecular evaluation of clonal remission in hairy cell leukemia patients treated with 2-chlorodeoxyadenosine. Leuk Lymph 14:139, 1994 (suppl 1)
13. Filleul B, Delannoy A, Ferrant A, Zeenebergh A, Van Daele S, Bosly A, Doyen C, Mineur P, Glorieux P, Driesschaert P, Sokal G, Martiat P, Michaux JL: A single course of 2-chloro-deoxyadenosine (2-CdA) does not eradicate leukemic cells in hairy cell leukemia (HCL) patients in complete remission. Leukemia 8:1153, 1994
14. Golomb H, Vardiman J: Response to splenectomy in 65 patients with hairy cell leukemia: Evaluation of spleen weight and bone involvement. Blood 61:369, 1983